Experienced in Erythroderma

Dr. Joseph F. Fowler

Dermatology
501 S 2nd St, 
Louisville, KY 
Accepting New Patients
Experienced in Erythroderma
501 S 2nd St, 
Louisville, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joseph Fowler is a Dermatologist in Louisville, Kentucky. Dr. Fowler is rated as an Experienced provider by MediFind in the treatment of Erythroderma. His top areas of expertise are Contact Dermatitis, Rosacea, Atopic Dermatitis, and Stasis Dermatitis and Ulcers. Dr. Fowler is currently accepting new patients.

His clinical research consists of co-authoring 143 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Erythroderma.

Specialties
Dermatology
Licenses
Dermatology in IN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

501 S 2nd St, Louisville, KY 40202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug
Study Drug: EB01 Cream
Study Phase: Phase 2
A Randomized, Double -Blind, Placebo-Controlled, Sequential, Multiple-Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Subjects With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double -Blind, Placebo-Controlled, Sequential, Multiple-Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Subjects With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Phase: Phase 1
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Enrollment Status: Completed
Publish Date: August 21, 2020
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects With Moderate-to- Severe Plaque Psoriasis
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects With Moderate-to- Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: June 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

143 Total Publications

Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study.
Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study.
Journal: Journal of the American Academy of Dermatology
Published: April 22, 2025
Similar Doctors
Experienced in Erythroderma
Dr. John D. Strickley
Dermatology
Experienced in Erythroderma
Dr. John D. Strickley
Dermatology

Associates In Dermatology, PLLC

3 Audubon Plaza Dr, Suite 630, 
Louisville, KY 
 (3.0 miles away)
502-583-1749
Languages Spoken:
English
See accepted insurances

John Strickley is a Dermatologist in Louisville, Kentucky. Dr. Strickley is rated as an Advanced provider by MediFind in the treatment of Erythroderma. His top areas of expertise are Squamous Cell Skin Carcinoma, Erythroderma, Scurvy, and Comedones.

Experienced in Erythroderma
Dr. Shannon M. Mcallister
Dermatology
Experienced in Erythroderma
Dr. Shannon M. Mcallister
Dermatology

Associates In Dermatology, PLLC

3810 Springhurst Blvd, 
Louisville, KY 
 (11.1 miles away)
502-583-1749
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shannon Mcallister is a Dermatologist in Louisville, Kentucky. Dr. Mcallister is rated as an Advanced provider by MediFind in the treatment of Erythroderma. Her top areas of expertise are Universal Acquired Melanosis, Liver Spots, Actinic Keratosis, and Warts. Dr. Mcallister is currently accepting new patients.

Experienced in Erythroderma
Dr. Mark A. Waldman
Dermatology
Experienced in Erythroderma
Dr. Mark A. Waldman
Dermatology

Vitalskin Medical Group Il PLLC

13802 Lake Point Cir, Suite 201, 
Louisville, KY 
 (13.6 miles away)
217-729-7868
Languages Spoken:
English
See accepted insurances

Mark Waldman is a Dermatologist in Louisville, Kentucky. Dr. Waldman is rated as a Distinguished provider by MediFind in the treatment of Erythroderma. His top areas of expertise are GAPO Syndrome, Actinic Keratosis, Spirurida Infections, and Dissecting Cellulitis of the Scalp.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fowler's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile